Neuroendocrine tumor (NET) disease is both rare and complex. About 15,000 new patients are diagnosed each year in the U.S. – which means that many medical professionals will only encounter neuroendocrine tumors a few times in their careers. With new research, technologies and practices emerging, the landscape of NET treatment is rapidly changing.
This Symposium is the premier gathering of medical professionals involved in the study and treatment of neuroendocrine tumor (NET) disease.
Saturday 21st October 2017
8:05am Clinical Management GI/pNETs
9:20am NANETS GI Symposium (Dr. Nirav Thosani)
Click here for the NANETS Symposium Website